Trileptal Tablet, Film Coated
Product Images NDC 0078-0337

Product Visual Gallery

This gallery contains 20 technical images submitted to the FDA as part of the official labeling for Trileptal (NDC 0078-0337). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxcarbazepine Structural Formula. (Trileptal 01)

FDA Label Image

Figure 1 Kaplan-meier Estimates Of Exit Rate By Treatment Group. (Trileptal 02)

FDA Label Image

Figure 2 Kaplan-meier Estimates Of First Seizure Event Rate By Treatment Group. (Trileptal 03)

FDA Label Image

Figure 3 Kaplan-meier Estimates Of Exit Rate By Treatment Group. (Trileptal 04)

FDA Label Image

Figure 4 Kaplan-meier Estimates Of Exit Rate By Treatment Group. (Trileptal 05)

FDA Label Image

Principal Display Panelpackage Label – 150 mgrx Only Ndc 0078-0456-05trileptal® (oxcarbazepine)100 Tabletspharmacist: Dispense With Medication Guide Attached Or Provided Separately. (Trileptal 06)

Trileptal® is a medication that comes in the form of tablets. The medication is only available via prescription (Rx only) and should be dispensed with a medication guide either attached or provided separately by the pharmacist. The medication is produced by NovarTis and has the NDC 0078 number. The text contains some alphanumeric codes and percentages of unknown context, and it also includes a string of numbers that cannot be understood. It ends with an address or a location signature "345 e Bas0Q".*

FDA Label Image

Principal Display Panelpackage Label – 300 mgrx Only Ndc 0078-0337-05trileptal® (oxcarbazepine)100 Tabletspharmacist: Dispense With Medication Guide Attached Or Provided Separately. (Trileptal 07)

Trileptal (oxcarbazepine) is a medication that comes in a pack of 100 tablets. The NDC code for this medication is 0078-0337-05 and it is for Rx use only. There is also a note for the pharmacist to dispense the medication with an attached medication guide or provided separately. The rest of the text contains some alphanumeric characters and symbols that are not readable and can not be interpreted.*

FDA Label Image

Principal Display Panelpackage Label – 600 mgrx Only Ndc 0078-0457-05trileptal® (oxcarbazepine)100 Tabletspharmacist: Dispense With Medication Guide Attached Or Provided Separately. (Trileptal 08)

Trileptal is a medication used for treating seizures. It's manufactured by Novartis and comes in the form of 100 tablets per bottle. The text includes dosage instructions that are not entirely clear, as well as references to a pharmacists' medication guide that must be provided along with the drug.*

FDA Label Image

Principal Display Panelpackage Label – 300 mg / 5 mLrx Only Ndc 0078-0357-52trileptal® Oral Suspension(oxcarbazepine)important: Shake Well Before Using.each 5 mL Contains 300 mg Oxcarbazepine.250 mLpharmacist: Dispense With Medication Guide Enclosed Or Provided Separately. (Trileptal 09)

This is a medication label containing information about the product name, dosage, and instructions for the pharmacist. The product name is Trileptal® (oxcarbazepine), and it is an oral suspension with a concentration of 300 mg per 5 mL. The label also includes a warning for the pharmacist to dispense with a medication guide included or provided separately, and instructions to store the product in the original container.*

FDA Label Image

1a (Trileptal 0a)

FDA Label Image

1b (Trileptal 0b)

FDA Label Image

1c (Trileptal 0c)

FDA Label Image

2d (Trileptal 0d)

FDA Label Image

2e (Trileptal 0e)

FDA Label Image

3f (Trileptal 0f)

FDA Label Image

3g (Trileptal 0g)

FDA Label Image

3h (Trileptal 0h)

FDA Label Image

3i (Trileptal 0i)

FDA Label Image

3j (Trileptal 0j)

FDA Label Image

3k (Trileptal 0k)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.